The cuprizone model for demyelination

被引:231
|
作者
Torkildsen, O. [1 ,2 ]
Brunborg, L. A. [3 ]
Myhr, K. -M. [1 ,2 ]
Bo, L. [1 ,2 ]
机构
[1] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway
[2] Univ Bergen, Dept Clin Med, Neurol Sect, N-5020 Bergen, Norway
[3] Natl Inst Nutr & Seafood Res, Bergen, Norway
来源
关键词
cuprizone; demyelination; multiple sclerosis;
D O I
10.1111/j.1600-0404.2008.01036.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background - Important advances in multiple sclerosis (MS) research have been made as a direct or indirect result of experiments in animal models for the disease, although MS is a disease only affecting humans. The cuprizone model is a model for toxic demyelination. In this model, young mice are fed with the copper chelator cuprizone, leading to oligodendrocyte death and a subsequent reversible demyelination. Spontaneous remyelination can be seen as early as 4 days after withdrawal of cuprizone. Materials and methods - This article reviews previous research on this model and discusses the potential of the model for future application in MS research. Discussion - The cuprizone model correlates with newer histopathological data in MS and is a valuable tool for studies on de- and remyelination. The use of the C57BL/6 strain offers the potential for future studies on transgene and knockout mice.
引用
收藏
页码:72 / 76
页数:5
相关论文
共 50 条
  • [1] Histopathological characterisation of the cuprizone model for demyelination
    Wergeland, S.
    Torkildsen, O.
    Myhr, K. M.
    Mork, S. J.
    Bo, L.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S177 - S177
  • [2] Demyelination of the hippocampus is prominent in the cuprizone model
    Koutsoudaki, Paraskevi N.
    Skripuletz, Thomas
    Gudi, Viktoria
    Moharregh-Khiabani, Darius
    Hildebrandt, Herbert
    Trebst, Corinna
    Stangel, Martin
    [J]. NEUROSCIENCE LETTERS, 2009, 451 (01) : 83 - 88
  • [3] Cerebellar Cortical Demyelination in the Murine Cuprizone Model
    Skripuletz, Thomas
    Bussmann, Jens-Heiko
    Gudi, Viktoria
    Koutsoudaki, Paraskevi N.
    Pul, Refik
    Moharregh-Khiabani, Darius
    Lindner, Maren
    Stangel, Martin
    [J]. BRAIN PATHOLOGY, 2010, 20 (02) : 301 - 312
  • [4] CD24 inhibits demyelination in a mouse cuprizone-demyelination model
    Ray-Chaudhury, Abhik
    Carl, Joseph W.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (05): : 516 - 517
  • [5] CD24 inhibits demyelination in a mouse cuprizone-demyelination model
    Ray-Chaudhury, Abhik
    Carl, Joseph W., Jr.
    [J]. FASEB JOURNAL, 2008, 22
  • [6] PET imaging of demyelination and remyelination in the cuprizone mouse model
    de Paula, Faria D.
    Copray, S.
    Sijbesma, J. W.
    Dierckx, R. A.
    de Vries, E. F.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S335 - S335
  • [7] A New Model of Cuprizone-Mediated Demyelination/Remyelination
    Sachs, Hilary H.
    Bercury, Kathryn K.
    Popescu, Daniela C.
    Narayanan, S. Priya
    Macklin, Wendy B.
    [J]. ASN NEURO, 2014, 6 (05):
  • [8] Evaluation strategy to determine reliable demyelination in the cuprizone model
    Uta Chrzanowski
    Christoph Schmitz
    Anja Horn-Bochtler
    Anne Nack
    Markus Kipp
    [J]. Metabolic Brain Disease, 2019, 34 : 681 - 685
  • [9] Altered transition metal homeostasis in the cuprizone model of demyelination
    Moldovan, Nataliya
    Al-Ebraheem, Alia
    Lobo, Lianne
    Park, Raina
    Farquharson, Michael J.
    Bock, Nicholas A.
    [J]. NEUROTOXICOLOGY, 2015, 48 : 1 - 8
  • [10] A Review of MRI Evaluation of Demyelination in Cuprizone Murine Model
    Krutenkova, E.
    Pan, E.
    Khodanovich, M.
    [J]. NEW OPERATIONAL TECHNOLOGIES (NEWOT'2015), 2015, 1688